Automated contrast medium monitoring system for Computed Tomography - Intra-institutional audit

Iodinated contrast media (CM) are the most widely consumed drugs by hospitals in imaging procedures [COMMENT #2, REVIEWER #4] around the world. As other pharmaceutical products, iodinated CM are not completely devoid of risk and may therefore be associated with adverse reactions, which can be classified as non-renal and renal [1]. Non-renal adverse reactions (incidence 0.5-1% [2–4]) are CM dose-independent and can be classified as acute (occurring within 1hour of CM administration), late (occurring 1hour to 1 week after CM administration) and very late (occurring more than 1 week after CM administration) [1].
Source: Computerized Medical Imaging and Graphics - Category: Radiology Authors: Source Type: research